why choose us

Clinical Trials Search

Showing 18,740 of 132,963 result(s)
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms

Status: Completed

Condition: Motion Sickness

Interventions: Interventional

Date: 2022-11-01

Predicting ICU Mortality in ARDS Patients

Status: Active, not recruiting

Condition: Acute Respiratory Distress Syndrome

Interventions: Other: machine learning analysis
We will use robust machine learning approaches, such as Random Forest, XGBoost or Neural Networks.
Other Na

Date: 2022-11-01

Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.

Status: Completed

Condition: Insomnia, Secondary
Sleep Disturbance
Sleep
Sleep Initiation and Maintenance Disorder

Interventions: Interventional

Date: 2022-11-01

Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC

Status: NOT_YET_RECRUITING

Condition: HPV-Related Squamous Cell Carcinoma

Interventions: Cisplatin (100 mg;m2 every 3 weeks)

Date: 2022-11-01

The Adaptive Physical Activity Study for Stroke

Status: Completed

Condition: Stroke

Interventions: Participants assigned to Structured Exercise will be provided with twice weekly strengthening exercise classes, delivered through the digital platform

Date: 2022-11-01

Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy

Status: COMPLETED

Condition: Colorectal Cancer

Interventions: Computer-aided detection (CADe) devices are used in conjunction with colonoscopy to aid in the detection of lesions in the gastrointestinal tract.

Date: 2022-11-01

Investigating the Relationship Between Nocturnal Glucose Levels and Motion During Sleep

Status: COMPLETED

Condition: Diabetes

Interventions:

Date: 2022-11-01

Implementation Outcome Assessments of the Emergency Department Delirium Screening and Detection Program

Status: ACTIVE_NOT_RECRUITING

Condition: Delirium

Interventions: Champions will participate in a 1-day workshop, consisting of patient testimonials, small group discussions, delirium and screening tool use (didactic

Date: 2022-11-01

Innate Immunity Stimulation Via TLR9 in Early AD

Status: Completed

Condition: Mild Cognitive Impairment

Interventions:

0.1 mg;kg dose administered via subcutaneous injection.

TLR9 agonist supplied by Dynavax Technologies Inc.

Date: 2022-11-01